Dario Continues to Expand its Employer Contracts Across Broad
Range of Solutions
NEW YORK, Sept. 9, 2021 /PRNewswire/ -- DarioHealth Corp.
(Nasdaq: DRIO), a leader in the global digital therapeutics (DTx)
market, announced today that it has entered into an agreement to
provide its suite of digital therapeutics for diabetes,
hypertension and pre-diabetes to a Northeast regional employer
("Employer"). The contract is expected to contribute revenue
beginning in the first quarter of 2022.
The Employer chose Dario to provide whole health support for the
frequently co-occurring conditions of diabetes and hypertension,
with one integrated approach. Dario's metabolic solution combines
innovative technologies and digital tools for condition management,
with weight management programs and live personal coaching, to
change the underlying health behaviors for improved whole
health.
Dario's metabolic solution is proven to improve clinical
outcomes with lasting results by analyzing billions of data points
in real-time to deliver a highly personalized experience that
adapts to each participant's unique and changing needs, making it
easy for users to stay engaged.
"Dario's metabolic solution combines the clinical rigor of
digital therapeutics with our expert track record of engaging
consumers to deliver a one-of-a-kind experience for our members.
This approach, which we believe is markedly different from current
market offerings, continues to gain significant traction in the
employer market, and we are excited to add another client to our
rapidly expanding employer vertical," said Rick Anderson, President and General Manager of
North America at DarioHealth.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading global digital
therapeutics company revolutionizing how people with chronic
conditions manage their health. DarioHealth offers one of the most
comprehensive digital therapeutics solutions on the market -
covering multiple chronic conditions including diabetes,
hypertension, weight management, musculoskeletal and behavioral
health within one integrated technology platform.
Dario's next-generation, AI-powered, digital therapeutic
platform supports more than just an individual's disease. Dario
provides adaptive, personalized experiences that drive behavior
change through evidence-based interventions, intuitive, clinically
proven digital tools, high-quality software, and coaching to help
individuals improve health and sustain meaningful outcomes.
Dario's unique user-centric approach to product design and
engagement creates an unparalleled experience that is highly rated
by users and delivers sustainable results.
The company's cross-functional team operates at the intersection
of life sciences, behavioral science, and software technology and
utilizes a performance-based approach to improve its users'
health.
On the path to better health, Dario makes the right thing to do
the easy thing to do. To learn more about DarioHealth and its
digital health solutions, or for more information, visit
http://www.dariohealth.com.
Cautionary Note Regarding Forward-Looking Statements
This news release and the statements of representatives and
partners of DarioHealth Corp. related thereto contain or may
contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. Statements that
are not statements of historical fact may be deemed to be
forward-looking statements. For example, the Company is using
forward-looking statements in this press release when it discusses
the expected timing of the contribution of revenues relating to the
agreement, the belief that its product offering is markedly
different from current market offerings and that it continues to
gain significant traction in the employer market. Without limiting
the generality of the foregoing, words such as "plan," "project,"
"potential," "seek," "may," "will," "expect," "believe,"
"anticipate," "intend," "could," "estimate" or "continue" are
intended to identify forward-looking statements. Readers are
cautioned that certain important factors may affect the Company's
actual results and could cause such results to differ materially
from any forward-looking statements that may be made in this news
release. Factors that may affect the Company's results include, but
are not limited to, regulatory approvals, product demand, market
acceptance, impact of competitive products and prices, product
development, commercialization or technological difficulties, the
success or failure of negotiations and trade, legal, social and
economic risks, and the risks associated with the adequacy of
existing cash resources. Additional factors that could cause or
contribute to differences between the Company's actual results and
forward-looking statements include, but are not limited to, those
risks discussed in the Company's filings with the U.S. Securities
and Exchange Commission. Readers are cautioned that actual results
(including, without limitation, the timing for and results of the
Company's commercial and regulatory plans for Dario™ as described
herein) may differ significantly from those set forth in the
forward-looking statements. The Company undertakes no obligation to
publicly update any forward-looking statements, whether as a result
of new information, future events or otherwise, except as required
by applicable law.
DarioHealth Corporate Contact
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Media Contact:
Josephine
Galatioto
Josephine.Galatioto@russopartnersllc.com
+1-212-845-4262
Logo -
http://mma.prnewswire.com/media/544126/DarioHealth_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/dariohealth-chosen-by-northeast-regional-employer-301372171.html
SOURCE DarioHealth Corp.